Table 4. Risk of childhood leukaemia associated with caesarean delivery and prelabour caesarean delivery.
Caesarean delivery (all indications) | Prelabour caesarean delivery | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of studies | Controls | Cases | OR* (95% CI) | Number of studies | Controls | Cases | OR* (95% CI) | |||||
CD | VD | CD | VD | PLCD | VD | PLCD | VD | |||||
Outcome | ||||||||||||
ALL | 13 | 3812 | 14 184 | 1877 | 6000 | 1.06 (0.99–1.13) | 4 | 325 | 4467 | 306 | 3238 | 1.23 (1.04–1.47), p=0.018 |
AML | 11 | 3179 | 11 917 | 251 | 937 | 0.99 (0.84–1.17) | 3 | 298 | 3815 | 34 | 525 | 0.83 (0.54–1.26) |
ALL immunophenotype† | ||||||||||||
B-cell | 10 | 3411 | 12 641 | 1324 | 4091 | 1.07 (0.99–1.15) | 3 | 267 | 3394 | 208 | 1867 | 1.23 (1.01–1.50), p=0.039 |
T-cell | 10 | 3411 | 12 641 | 150 | 519 | 0.97 (0.80–1.18) | 3 | 267 | 3394 | 26 | 275 | 1.11 (0.72–1.72) |
Risk of ALL by subgroup† | ||||||||||||
Age at diagnosis (years)‡ | ||||||||||||
0 | 13 | 312 | 1155 | 62 | 190 | 1.14 (0.79–1.64) | 4 | 13 | 305 | 11 | 96 | 2.62 (0.96–7.19) |
0–3 | 13 | 1883 | 6327 | 927 | 2679 | 1.05 (0.95–1.17) | 4 | 125 | 1743 | 148 | 1405 | 1.42 (1.09–1.83), p=0.0079 |
1–5 | 13 | 2411 | 7979 | 1293 | 3769 | 1.04 (0.96–1.14) | 4 | 210 | 2454 | 201 | 1982 | 1.19 (0.96–1.47) |
6–10 | 13 | 732 | 3269 | 386 | 1430 | 1.12 (0.96–1.30) | 4 | 63 | 1024 | 64 | 775 | 1.32 (0.91–1.93) |
11–14 | 12 | 339 | 1706 | 136 | 611 | 1.00 (0.78–1.27) | 4 | 39 | 684 | 30 | 385 | 1.13 (0.65–1.94) |
Year of birth | ||||||||||||
1970–79 | 4 | 85 | 543 | 55 | 329 | 1.06 (0.70–1.60) | 2 | 17 | 386 | 11 | 304 | 1.13 (0.46–2.80) |
1980–89 | 9 | 806 | 3489 | 535 | 2049 | 1.01 (0.89–1.15) | 3 | 119 | 1870 | 122 | 1523 | 1.30 (0.99–1.72) |
1990–99 | 13 | 1613 | 6439 | 690 | 2300 | 1.07 (0.95–1.19) | 4 | 77 | 1045 | 75 | 703 | 1.25 (0.88–1.78) |
2000–09 | 9 | 1237 | 3528 | 575 | 1296 | 1.12 (0.98–1.28) | 2 | 102 | 1015 | 91 | 688 | 1.09 (0.79–1.50) |
2010–13 | 4 | 71 | 185 | 22 | 26 | 1.54 (0.69–3.42) | 2 | 10 | 151 | 7 | 20 | 3.92 (0.98–15.70) |
Gestational age | ||||||||||||
Early preterm | 12 | 137 | 154 | 49 | 53 | 1.12 (0.66–1.91) | 4 | 6 | 46 | 6 | 35 | 0.88 (0.19–4.10) |
Late preterm | 12 | 299 | 591 | 140 | 254 | 1.07 (0.81–1.42) | 4 | 18 | 165 | 17 | 113 | 1.39 (0.61–3.14) |
Early term | 12 | 773 | 2152 | 375 | 837 | 1.11 (0.94–1.31) | 4 | 82 | 588 | 92 | 422 | 1.35 (0.95–1.93) |
Full term | 12 | 1473 | 6759 | 671 | 2786 | 1.01 (0.90–1.13) | 4 | 142 | 2212 | 135 | 1709 | 1.23 (0.95–1.59) |
Late term | 11 | 649 | 3220 | 296 | 1308 | 1.04 (0.88–1.22) | 4 | 15 | 985 | 8 | 641 | 0.85 (0.34–2.11) |
Child's ethnic origin§¶ | ||||||||||||
White | 4 | 1237 | 4316 | 472 | 1569 | 1.04 (0.91–1.19) | .. | .. | .. | .. | .. | .. |
Black | 4 | 122 | 306 | 37 | 113 | 0.74 (0.44–1.24) | .. | .. | .. | .. | .. | .. |
Asian | 4 | 102 | 383 | 26 | 121 | 0.85 (0.48–1.51) | .. | .. | .. | .. | .. | .. |
Hispanic | 4 | 300 | 1178 | 146 | 467 | 1.14 (0.89–1.47) | .. | .. | .. | .. | .. | .. |
Other | 4 | 43 | 165 | 20 | 67 | 1.23 (0.62–2.45) | .. | .. | .. | .. | .. | .. |
Child's ethnic origin (age 2–5 years)§¶ | ||||||||||||
White | 4 | 685 | 2198 | 295 | 862 | 1.06 (0.88–1.26) | .. | .. | .. | .. | .. | .. |
Black | 4 | 65 | 148 | 18 | 47 | 0.65 (0.29–1.44) | .. | .. | .. | .. | .. | .. |
Asian | 4 | 57 | 208 | 17 | 77 | 0.91 (0.43–1.89) | .. | .. | .. | .. | .. | .. |
Hispanic | 4 | 137 | 632 | 90 | 272 | 1.36 (0.97–1.92) | .. | .. | .. | .. | .. | .. |
Other | 4 | 28 | 83 | 11 | 40 | 0.86 (0.32–2.27) | .. | .. | .. | .. | .. | .. |
OR=odds ratio. CD=caesarean delivery. VD=vaginal delivery. PLCD=prelabour caesarean delivery. ALL=acute lymphoblasic leukaemia. AML=acute myeloid leukaemia.
Adjusted for birthweight, sex, ethnic origin, maternal age, child's age at diagnosis or reference date, parental education, and study.
Analyses include ALL cases only.
ORs adjusted for birthweight, sex, ethnic origin, maternal age, parental education, and study.
Analyses include the four US studies only.
ORs adjusted for birthweight, sex, maternal age, child's age at diagnosis or reference date, parental education, and study.